Menu Close

Investeringsforeningen Carnegie Wealth Management – Prospekt

view original post

Business Wire

ADC Therapeutics to Participate in the Jefferies London Healthcare Conference

LAUSANNE, Switzerland, November 09, 2021–ADC Therapeutics SA (NYSE: ADCT), a commercial-stage biotechnology company improving the lives of those affected by cancer with its next-generation, targeted antibody drug conjugates (ADCs) for patients with hematologic malignancies and solid tumors, announced today that Chris Martin, PhD, Chief Executive Officer, will participate in a fireside chat at the Jefferies London Healthcare Conference on Tuesday, November 16th at 11:20 a.m. GMT / 6:20 a.m. EST.